Evidence map›Paper›PMID 33630757›Full record

ArticleThe Journal of clinical investigation2021

Lymphohematopoietic graft-versus-host responses promote mixed chimerism in patients receiving intestinal transplantation.

Jianing Fu, Julien Zuber, Brittany Shonts, Aleksandar Obradovic, Zicheng Wang, Kristjana Frangaj, Wenzhao Meng, Aaron M Rosenfeld, Elizabeth E Waffarn, Peter Liou and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Immunogenomic landscape of the T cell repertoire after human lung transplantation and its clinical relevance.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Tolerance Induction Strategies in Organ Transplantation: Current Status and Future Perspectives.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  15. Chimerism-Mediated Tolerance in Intestinal Transplantation.Gastroenterology clinics of North America · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 1 country.

Jianing FuColumbia Center for Translational Immunology, Department of Medicine and.
Julien ZuberColumbia Center for Translational Immunology, Department of Medicine and.
Brittany ShontsColumbia Center for Translational Immunology, Department of Medicine and.
Aleksandar ObradovicColumbia Center for Translational Immunology, Department of Medicine and.
Zicheng WangCenter for Computational Biology and Bioinformatics, Department of Systems Biology, Columbia University, New York, New York, USA.
Kristjana FrangajColumbia Center for Translational Immunology, Department of Medicine and.
Wenzhao MengDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Aaron M RosenfeldDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Elizabeth E WaffarnColumbia Center for Translational Immunology, Department of Medicine and.
Peter LiouDepartment of Surgery.
Sai-Ping LauColumbia Center for Translational Immunology, Department of Medicine and.
Thomas M SavageColumbia Center for Translational Immunology, Department of Medicine and.
Suxiao YangColumbia Center for Translational Immunology, Department of Medicine and.
Kortney RogersColumbia Center for Translational Immunology, Department of Medicine and.
Nichole M DanzlColumbia Center for Translational Immunology, Department of Medicine and.
Shilpa RavellaDivision of Digestive and Liver Diseases, Department of Medicine.
Prakash SatwaniDepartment of Pediatrics.
Alina IugaDepartment of Pathology and Cell Biology, and.
Siu-Hong HoColumbia Center for Translational Immunology, Department of Medicine and.
Adam GriesemerColumbia Center for Translational Immunology, Department of Medicine and.
Yufeng ShenCenter for Computational Biology and Bioinformatics, Department of Systems Biology, Columbia University, New York, New York, USA.
Eline T Luning PrakDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Mercedes MartinezDepartment of Pediatrics.
Tomoaki KatoDepartment of Surgery.
Megan SykesColumbia Center for Translational Immunology, Department of Medicine and.
Columbia University · USUniversity of Pennsylvania · USPediatrics and Genetics · USCenter for Digestive and Liver Diseases · US

Funding

Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber · 2013 to 2026
$31.3M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
Becton Dickinson LSR II Analytical Flow CytometerS10RR027050 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLYNES, RAPHAEL A. · 2011 to 2011
$413k
NCRR NIH HHS S10 RR027050NIAID NIH HHS P01 AI106697NIH HHS S10 OD020056
6 · The paper itself

Abstract

In humans receiving intestinal transplantation (ITx), long-term multilineage blood chimerism often develops. Donor T cell macrochimerism (≥4%) frequently occurs without graft-versus-host disease (GVHD) and is associated with reduced rejection. Here we demonstrate that patients with macrochimerism had high graft-versus-host (GvH) to host-versus-graft (HvG) T cell clonal ratios in their allografts. These GvH clones entered the circulation, where their peak levels were associated with declines in HvG clones early after transplant, suggesting that GvH reactions may contribute to chimerism and control HvG responses without causing GVHD. Consistently, donor-derived T cells, including GvH clones, and CD34+ hematopoietic stem and progenitor cells (HSPCs) were simultaneously detected in the recipients' BM more than 100 days after transplant. Individual GvH clones appeared in ileal mucosa or PBMCs before detection in recipient BM, consistent with an intestinal mucosal origin, where donor GvH-reactive T cells expanded early upon entry of recipient APCs into the graft. These results, combined with cytotoxic single-cell transcriptional profiles of donor T cells in recipient BM, suggest that tissue-resident GvH-reactive donor T cells migrated into the recipient circulation and BM, where they destroyed recipient hematopoietic cells through cytolytic effector functions and promoted engraftment of graft-derived HSPCs that maintain chimerism. These mechanisms suggest an approach to achieving intestinal allograft tolerance.

Indexed as

Organ TransplantationAllograftsFemaleGraft vs Host DiseaseHumansIntestinesLymphopoiesisMaleT-LymphocytesTransplantation ChimeraImmunologyOrgan transplantationT cellsToleranceTransplantation

Identifiers

PMID33630757
PMCPMC8062082
OpenAlexW3131260318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.